Table of Contents

company-logo

TaiGen Biopharmaceuticals Holdings Limited, a pharmaceutical company, develops novel therapeutics for transformative diseases worldwide. The company develops Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic for the treatment of bacterial infections. It is also developing Taigexyn for treating community-acquired pneumonia and diabetic foot infection, as well as other bacterial infections; Burixafor, a stem cell mobilizer for stem cell transplantation and chemosenzitization; TG-1000, an influenza antiviral drug for treating influenza A, B, and avian influenza H7N9; and Furaprevir, a hepatitis C virus protease inhibitor for the treatment of chronic hepatitis C. The company was founded in 2001 and is based in Taipei City, Taiwan.

TaiGen Biopharmaceuticals Dividend Announcement

• TaiGen Biopharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on TaiGen Biopharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

TaiGen Biopharmaceuticals Dividend History

TaiGen Biopharmaceuticals Dividend Yield

TaiGen Biopharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing TaiGen Biopharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

TaiGen Biopharmaceuticals Financial Ratios

P/E ratio40.80
PEG ratio9.42
P/B ratio8.19
ROE21.82%
Payout ratio0.00%
Current ratio20.34
Quick ratio19.50
Cash Ratio3.37

TaiGen Biopharmaceuticals Dividend FAQ

Does TaiGen Biopharmaceuticals stock pay dividends?
TaiGen Biopharmaceuticals does not currently pay dividends to its shareholders.
Has TaiGen Biopharmaceuticals ever paid a dividend?
No, TaiGen Biopharmaceuticals has no a history of paying dividends to its shareholders. TaiGen Biopharmaceuticals is not known for its dividend payments.
Why doesn't TaiGen Biopharmaceuticals pay dividends?
There are several potential reasons why TaiGen Biopharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will TaiGen Biopharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While TaiGen Biopharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is TaiGen Biopharmaceuticals a dividend aristocrat?
TaiGen Biopharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is TaiGen Biopharmaceuticals a dividend king?
TaiGen Biopharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is TaiGen Biopharmaceuticals a dividend stock?
No, TaiGen Biopharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy TaiGen Biopharmaceuticals stocks?
To buy TaiGen Biopharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy TaiGen Biopharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.